Fovus participated in the Amazon Web Services (AWS) Startup Summit in San Francisco to share its platform and push deeper into enterprise.
Published
Signal category
Presence & Recognition
Quote
āAt the Amazon Web Services (AWS) Startup Summit in San Francisco this week, we shared where Fovus stands as we push deeper into enterprise.ā
ā Fovus team
Company
Fovus
The world's first AI-powered serverless HPC platform for bioinformatics, computational chemistry, simulations, and AI
- Industry
- Software Development
- Location
- Phoenix, US
- Company size
- 14 employees
š šØšÆš®š¬ š¢š¬ šš”š ššØš«š„š'š¬ š š¢š«š¬š šš-ššØš°šš«šš ššš«šÆšš«š„šš¬š¬ ššš šš„ššššØš«š¦, built for scientists and engineers accelerating drug discovery, engineering simulations, and AI research. GPU scarcity, long queues, manual benchmarking, and job failures slow the world's most valuable scientific workloads down and burn millions in cloud spend. Fovus removes these bottlenecks. The platform benchmarks every workload to choose the optimal instance, parallelizes across AWS regions to unlock capacity, and runs on Spot with memory checkpointing so interruptions don't kill long jobs. šš”š šØš®šššØš¦š: šØšÆšš« šššš± ššš¬ššš« šš¢š¦š-ššØ-š¢š§š¬š¢š š”š. šš% ššØ šš% š„šØš°šš« ššØš¦š©š®šš ššØš¬š. These results are published. In a benchmarking study on the AWS Partner Network blog, co-authored with AWS, Fovus delivered nf-core/rnaseq at $0.70 per sample and 30x whole genome sequencing with sarek at $6.15 per sample, running 3x faster. An AWS HPC and Software Competency Partner, Fovus powers compute for enterprise pharma, biotech, and research teams running Nextflow (RNA-seq, sarek WGS), AlphaFold, Boltz, and GROMACS.
Founded 2021